| Title | Hypocalcemia in a Dialysis Patient Treated With Deferasirox for Iron Overload. | | Author(s) | Yusuf B, McPhedran P, Brewster UC | | Institution | Section of Nephrology, Yale University School of Medicine, New Haven, CT. | | Source | Am J Kidney Dis 2008 Jun 4. | | Abstract | Deferasirox is a new iron chelator approved recently for chelation therapy in iron-overloaded patients. It is considered safe and efficacious in most patients, but has not been tested formally in patients with end-stage renal disease. We report a case of a patient with end-stage renal disease secondary to sickle cell nephropathy who developed recurrent symptomatic hypocalcemia while on therapy and later reexposure with this medication for iron overload from long-term blood transfusions. This is the first case report of this complication with deferasirox therapy in a patient with end-stage renal disease. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 18534729 |
|
